Navigation Links
Most Men With Low-Risk Prostate Cancer Treated Aggressively, Study Shows
Date:7/27/2010

By Steven Reinberg
HealthDay Reporter

MONDAY, July 26 (HealthDay News) -- Too many men with low-risk prostate cancers, those whose level of prostate-specific antigen (PSA) is normal or below normal, still receive aggressive treatment, a new study shows.

Recent evidence has shown that among older men with low-risk prostate cancer, it's not the cancer they die from, but another condition. For these men, watchful waiting is probably better than surgery or radiation therapy, the researchers noted.

"The difficulty we have right now is that we need further efforts in research to understand who is who, and individualize treatment in a better way," said lead researcher Dr. Robert S. DiPaola, director of the Cancer Institute of New Jersey and associate dean for oncology programs and professor of medicine at UMDNJ-Robert Wood Johnson Medical School in New Brunswick, N.J.

Understanding more about prostate cancer will enable doctors to make better use of the therapies available, he added. "Obviously, there is a large population, if we knew who they were, [that] would not need that therapy," he said.

But on an individual basis, the decision whether to have aggressive treatment or not is complex, DiPaola noted. Because the decision may be different "depending on age, aggressiveness of the tumor, the PSA level, this is a call to action that patients need a very informed discussion. They need all those things considered, and the approach needs to be individualized," he said.

The report is published in the July 26 issue of the Archives of Internal Medicine.

For the study, DiPaola's team collected data on 123,934 men with prostate cancer who were listed in the Surveillance, Epidemiology and End Results (SEER) system. Among these men, 14 percent had PSA levels at or below 4 nanograms per milliliter, which is normal or below normal. These patients were likely to have low-risk cancer, the researchers say.'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. What is the role of focal therapy in low-risk prostate cancer?
2. Value of Monitoring Low-Risk Prostate Cancer Assessed
3. Delay in surgery not likely to worsen tumors in men with low-risk prostate cancer
4. Surveillance may be suitable treatment option for patients with low-risk prostate cancer
5. Most men with low-risk prostate cancer receive aggressive treatment
6. Advance Toward Test for Aggressive Prostate Cancer
7. DASH FOR DAD Race Series Coming to 11 Cities to Raise Prostate Cancer Awareness
8. Jim Huber to Serve as National Spokesman for Know Your Score: Fight Prostate Campaign at Myrtle Beach Golf Holiday in August
9. Few differences in outcomes between open and laparoscopic prostate surgery
10. Two Surgical Methods Equally Successful for Prostate Cancer
11. Genetic Mutation Linked to Prostate Cancer in Blacks
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Most Men With Low-Risk Prostate Cancer Treated Aggressively, Study Shows
(Date:7/25/2014)... MEDICC announced diplomas went to 1,382 new MDs ... of Havana’s graduation ceremonies that also included graduates of ... 879 international graduates from 28 countries, 20 were ... and hundreds of parents packed the Cuban labor union ... President Ramón Machado Ventura and Minister of Health Roberto ...
(Date:7/25/2014)... the leading pan-European association representing medical oncology professionals, ... Data Protection Regulation [1] could make cancer research ... doctors and cancer patients. , The proposed wording ... patient consent, meaning that researchers would have to ... in order to consult their data or use ...
(Date:7/25/2014)... Mahendra Trivedi and his wife Dahryn ... is Power’ on Saturday, July 26, 2014. People from ... life transforming event as they will get a chance ... days are left for the commencement of this rare ... Masters™ Dahryn Trivedi (his wife) and Alice Branton will ...
(Date:7/25/2014)... 25, 2014 CMS recently has imposed ... for providing inadequate access to prescription drugs. Agency audits ... health and safety of beneficiaries in areas such as ... and CMS is taking quick and firm actions to ... Services webinar, “Avoiding Costly Part D Sanctions: Rx ...
(Date:7/25/2014)... Abilene, Texas (PRWEB) July 25, 2014 Yisrayl ... posted a new article on his blog explaining why so ... are needed the most. , In the article, Yisrayl ... going out and shares the results. For example, in one ... displayed all over church grounds to pray for rain; ironically, ...
Breaking Medicine News(10 mins):Health News:MEDICC Congratulates 20 New MDs for the USA Graduating from Cuba’s Latin American Medical School 2Health News:MEDICC Congratulates 20 New MDs for the USA Graduating from Cuba’s Latin American Medical School 3Health News:Is Europe putting cancer research at risk? 2Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 2Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 3Health News:Aug. 5 Webinar to Offer Strategies for Preventing Rx Access Issues and Avoiding Part D Sanctions 2Health News:Yisrayl Hawkins Says Prayers for Rain Result in Violent Hail Because Prayers Are Not Being Heard in New Post 2Health News:Yisrayl Hawkins Says Prayers for Rain Result in Violent Hail Because Prayers Are Not Being Heard in New Post 3
... Nov. 3 Rib-X Pharmaceuticals, Inc.,("Rib-X" or the ... development of novel antibiotics for the treatment of,antibiotic-resistant ... Chief Executive Officer, is scheduled to present at ... Monday, November 10,2008 at 2:00pm EST. The conference ...
... TSX: BMR, TORONTO, Nov. 3 /PRNewswire-FirstCall/ - ... development and,commercialization of cancer therapies, announced today that ... of the Company, will present a,corporate update at ... being held in New York City from November ...
... Most frequent tumor sites were cervix, head and neck, ... -- An estimated 25,000 cases of cancers associated with ... District of Columbia between 1998 and 2003, U.S. officials ... that includes more than 100 different types, more than ...
... study comparing cancer rates of liver transplant patients to ... recipients face increased risks of developing cancer, especially non-Hodgkin,s ... the first year of follow-up and among younger transplant ... of Liver Transplantation , a journal by John ...
... new studies conclude that a review which claimed that homeopathy ... was seriously flawed. , George Lewith, Professor of ... indication of which trials were analysed nor of the various ... scientific practice. If we presume that homeopathy works for some ...
... genetic vulnerability , , MONDAY, Nov. 3 (HealthDay News) ... States that get a lot of precipitation appear to ... study suggests. , Because these children may spend more ... atmosphere to the ground, they might be exposed to ...
Cached Medicine News:Health News:Rib-X Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference 2Health News:Bradmer to present at Rodman & Renshaw Healthcare Conference 2Health News:Bradmer to present at Rodman & Renshaw Healthcare Conference 3Health News:U.S. Reported 25,000 Cases of HPV-Related Cancers Annually 2Health News:Liver transplant recipients have higher cancer risk 2Health News:New evidence for homeopathy 2Health News:Rainier Spots Show Higher Autism Rates 2Health News:Rainier Spots Show Higher Autism Rates 3Health News:Rainier Spots Show Higher Autism Rates 4
(Date:7/24/2014)... 2014 Omnicell, Inc. (NASDAQ: ... supply management solutions and analytics software for healthcare ... to discuss the Company,s Second Quarter 2014 financial ... earnings conference call and webcastWhen: , July ... chairman, president and chief executive officer ...
(Date:7/24/2014)... 24, 2014  IGI Laboratories, Inc. (NYSE MKT: IG), a ... announced its financial results for the second quarter ended June ... , Total revenues of $6.5 million in the second quarter ... in 2013 , Total revenues of $13.3 million for ... 78% over the same period in 2013 , Total ...
(Date:7/24/2014)... LOS ANGELES , July 24, 2014 Many ... what they can do to ensure that their practice will ... dentists purchase the basic supplies they use the most can ... other, and many dentists have recently discovered that purchasing ... and loss. According to successful dentists across ...
Breaking Medicine Technology:Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7Dental Supplies Online is Key to Dental Success...Really! 2
... /PRNewswire/ -- PRA International, a leading Clinical Research ... during the 8th Annual Partnerships in Clinical Trials 2009 to ... Trade Centre in Rotterdam, The Netherlands. PRA operational and ... exhibiting at booth number 32. , On 4 November, PRA,s ...
... Shire plc (LSE: SHP, NASDAQ:,SHPGY) the global specialty biopharmaceutical company, announces results for,the three months to September 30, 2009. , , ... ... sales ... Product sales from core products(2) $532 ...
Cached Medicine Technology:PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009 2Shire Continues to Deliver Excellent Growth From Core Products 2Shire Continues to Deliver Excellent Growth From Core Products 3Shire Continues to Deliver Excellent Growth From Core Products 4Shire Continues to Deliver Excellent Growth From Core Products 5Shire Continues to Deliver Excellent Growth From Core Products 6Shire Continues to Deliver Excellent Growth From Core Products 7Shire Continues to Deliver Excellent Growth From Core Products 8Shire Continues to Deliver Excellent Growth From Core Products 9Shire Continues to Deliver Excellent Growth From Core Products 10Shire Continues to Deliver Excellent Growth From Core Products 11Shire Continues to Deliver Excellent Growth From Core Products 12Shire Continues to Deliver Excellent Growth From Core Products 13Shire Continues to Deliver Excellent Growth From Core Products 14Shire Continues to Deliver Excellent Growth From Core Products 15Shire Continues to Deliver Excellent Growth From Core Products 16Shire Continues to Deliver Excellent Growth From Core Products 17Shire Continues to Deliver Excellent Growth From Core Products 18Shire Continues to Deliver Excellent Growth From Core Products 19Shire Continues to Deliver Excellent Growth From Core Products 20Shire Continues to Deliver Excellent Growth From Core Products 21Shire Continues to Deliver Excellent Growth From Core Products 22Shire Continues to Deliver Excellent Growth From Core Products 23Shire Continues to Deliver Excellent Growth From Core Products 24Shire Continues to Deliver Excellent Growth From Core Products 25Shire Continues to Deliver Excellent Growth From Core Products 26Shire Continues to Deliver Excellent Growth From Core Products 27Shire Continues to Deliver Excellent Growth From Core Products 28Shire Continues to Deliver Excellent Growth From Core Products 29Shire Continues to Deliver Excellent Growth From Core Products 30Shire Continues to Deliver Excellent Growth From Core Products 31Shire Continues to Deliver Excellent Growth From Core Products 32Shire Continues to Deliver Excellent Growth From Core Products 33
... lens, doctors have to make a trade off ... Now, with the Digital Wide Field lens ... both in one lens. This lens provides ... non-contact lens paired with the higher magnification required ...
... The Stryker Wedge Suture Anchors are titanium ... and styles. The Wedge anchors are simple ... and OR staff. The following sizes and ... Suture, 5.0mm Single Eyelet 2 Sutures, 5.0mm ...
... Suture Anchor is a 3.0mm single loaded ... (PLLA). The anchor barb catches on the ... until it "breaks" free. The small size ... also frequently used in rotator cuff repair ...
... absorbable co-polymer synthesized from all-natural ingredients: ... acid. Unlike the homopolymers in common ... (PLLA) or 100% poly-glycolic acid (PGA), ... crystallinity), meaning that its degradation is ...
Medicine Products: